ALISON THOMPSON: Open Payments
NPI 1437745528 · RIGBY, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 34 payments from 8 companies in 2025. Trend: 2023 $238 · 2024 $1,050 · 2025 $656
Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $332 |
| Phathom Pharmaceuticals, Inc. | 3 | $95 |
| Vanda Pharmaceuticals Inc. | 3 | $64 |
| Axsome Therapeutics, Inc. | 3 | $63 |
| UCB, Inc. | 1 | $39 |
| Indivior Inc. | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $13 |
Products named: QULIPTA, VRAYLAR, VOQUEZNA, FANAPT, Auvelity, Bimzelx, SUBLOCADE, UBRELVY.
Industry payments across ID — which companies pay providers there.
